Equity

12 Months Ended

Mar. 31, 2026

Equity [Abstract]

Equity

10. Equity

a.

Share capital and additional paid-in capital

The addition of share capital and additional paid-in capital represented:

	(i)	The issuance of 1,125,000 ordinary shares in private placement on June 12, 2023;

	(ii)	The issuance of 1,125,000 ordinary shares in private placement on December 1, 2023;

	(iii)	The issuance of 600,000 ordinary shares in private placement on January 5, 2024;

	(iv)	The issuance of 600,000 ordinary shares in private placement on January 9, 2024;

	(v)	The issuance of 800,000 ordinary shares in private placement on January 11, 2024;

	(vi)	The issuance of 300,000 ordinary shares in private placement on February 29, 2024;

	(vii)	The issuance of 1,650,000 ordinary shares under share incentive plans; and

	(viii)	The issuance of 1,125,000 ordinary shares in private placement on May 24, 2024;

	(ix)	The issuance of 1,125,000 ordinary shares in private placement on December 9, 2024;

	(x)	The issuance of 1,929,912 ordinary shares in private placement on June 23, 2025;

	(xi)	The issuance of 1,240,734 ordinary shares in private placement on November 7, 2025;

	(xii)	The issuance of 826,419 ordinary shares in private placement on November 13, 2025;

	(xiii)	The issuance of 3,257,300 ordinary shares in private placement on December 2, 2025;

	(xiv)	The issuance of 360,500 ordinary shares in private placement on February 27, 2026;

b.

Warrants reserves

Warrants are issued to management team and consultants on trading of digital assets as an incentive to boost overall performance of the company.

A continuity schedule of outstanding share purchase warrants and fair value charged to profit or loss are as follows:

		Number of warrants outstanding

At April 1, 2024			32,900,000
Early termination			(14,000,000	)
At March 31, 2025, April 1, 2025 and March 31, 2026			18,900,000

On December 23, 2023, the Company issued 300,000 share purchase warrants to Hermitage Management Limited and they are exercisable at US$1.00 per share, for a period of five years.

On September 26, 2024, the Company entered into a deed of termination with Natural Selection Capital Holding Limited which wholly owned by Mr. Bingzhong Wang, the director of the Company.

The fair value of the warrants was calculated at the respective grant date. The fair value of the warrants granted during the year ended March 31, 2024 was US$411,403.

The Company’s share purchase warrants are valued by independent professional qualified valuer by using binomial option pricing models. The inputs into the model were as follows:

		As of March 31, 2026				As of March 31, 2025

Risk-free interest rate			3.8	%			3.8	%
Expected life of warrants			2 years				3 years
Volatility			81.89	%			81.89	%
Weighted average fair value per warrant (US$)			1.37				1.37
Risk-free interest rate			3.8	%			3.8

As of March 31, 2025 and 2026, the Company had share purchase warrants outstanding as follows:

		Warrants outstanding as of March 31, 2025				Termination				Warrants outstanding as of March 31, 2026				Fair value at issue date				Fair value charged for current year				Exercise price				Weighted average remaining life
Expiry Date														US$				US$				US$				(years)
October 27, 2026			1,800,000				—				1,800,000				1,353,304				—				1.5				1
October 29, 2026			2,000,000				—				2,000,000				1,417,766				—				1.5				1
May 10, 2027			200,000				—				200,000				84,000				—				1.5				2
May 26, 2027			500,000				—				500,000				238,000				—				1.5				2
July 22, 2027			440,000				—				440,000				163,000				—				1				2
July 25, 2027			3,780,000				—				3,780,000				1,405,000				—				1				2
July 26, 2027			400,000				—				400,000				146,000				—				1				2
July 27, 2027			1,000,000				—				1,000,000				379,000				—				1				2
July 28, 2027			980,000				—				980,000				376,000				—				1				2
November 28, 2027			1,125,000				—				1,125,000				264,000				—				1				2
November 28, 2027			1,125,000				—				1,125,000				274,000				—				1				2
November 28, 2027			1,125,000				—				1,125,000				289,000				—				1				2
November 28, 2027			1,125,000				—				1,125,000				303,000				—				1				2
November 28, 2032			750,000				—				750,000				263,000				—				1.5				7
November 28, 2032			250,000				—				250,000				89,000				—				1.5				6
November 28, 2032			500,000				—				500,000				165,000				—				2.5				7
November 28, 2032			500,000				—				500,000				169,000				—				2.5				7
November 28, 2032			250,000				—				250,000				87,000				—				6				7
November 28, 2032			750,000				—				750,000				258,000				—				6				7
December 23, 2028			300,000				—				300,000				411,403				—				1				2
Total			18,900,000				—				18,900,000				8,134,473				—

Movement of respective share purchase warrants was shown below:

		Share purchase warrants
		2026				2025
		US$				US$
At the beginning of financial year			24,379,389				22,699,351
Additions and recognized in profit or loss			—				1,680,038
Adjustment of warrants terminated			(16,244,916	)			—
At the end of financial year			8,134,473				24,379,389

(c)

Share award reserve

On June 30, 2022, the Company implemented its 2022 Performance Incentive Plan (“Plan”) to foster the success of the Company and to increase shareholder value by providing an additional means, through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons, and to enhance the alignment of the interests of such selected participants with the interests of the Company’s shareholders. Under the Plan, an aggregate of 3,300,000 ordinary shares of US$0.0001 par value each of the Company are reserved for issuance for purposes of the Plan, subject to adjustments as contemplated by the Plan.

On November 19, 2024, the Company implemented its 2024 Performance Incentive Plan (“2024 Plan”) to foster the success of the Company and to increase shareholder value by providing an additional means, through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons, and to enhance the alignment of the interests of such selected participants with the interests of the Company’s shareholders. Under the 2024 Plan, an aggregate of 2,000,000 ordinary shares of US$0.0001 par value each of the Company are reserved for issuance for purposes of the 2024 Plan, subject to adjustments as contemplated by the 2024 Plan.

		Number of share awards grant
		2026				2025

At the beginning of financial year			—				—
Grant during the year			3,141,000				—
At the end of financial year			3,141,000				—

The fair value of the share awards was calculated based on the market price of the Company’s shares at the respective grant date. The fair value of the share awards granted during the year 2026 was US$3,284,311 and the Company recognized as share-based compensation expense of US$3,284,311 during the year ended March 31,2026.

(d)

Accumulated deficit

The accumulated deficit comprises the cumulative net profit and losses for the year recognized in the consolidated statements of profit or loss.

(e)

Accumulated other comprehensive (loss) income

Accumulated other comprehensive (loss) income represents the foreign currency translation difference arising from the translation of the financial statements of companies within the Company from their functional currency to the Company’s presentation currency.

(f)

Treasury shares

On March 15, 2023, the Company repurchased 329,582 Shares of the Company by way of brokers platform at a consideration of US$353,816 (including transaction costs).

In April, 2023, the Company repurchased 79,758 Shares of the Company by way of brokers platform at a consideration of US$82,127 (including transaction costs).

In March 2026, the Company repurchased 16,130 shares of the Company by way of brokers platform at consideration of US$18,340 (including transaction costs).